• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1070250-48
Device Problems Off-Label Use (1494); Difficult to Remove (1528); Material Separation (1562)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/11/2021
Event Type  Injury  
Event Description
It was reported that the procedure was to treat a heavily calcified posterior tibial artery.A non-abbott balloon was used and the device ruptured and separated, but was able to be retrieved during sheath withdrawal.The sheath was then exchanged for another.A 4f sheath was positioned in the popliteal artery, which had been introduced via a short 6f sheath from the common femoral artery to the superficial femoral artery.Then a 2.5x48mm xience xpedition stent was advanced and stent implanted successfully without issue.During withdrawal of the delivery system resistance was met with the introducer sheath and the shaft separated.A snare maneuver was attempted but it was not possible to snare over the stent-balloon.The 4f sheath was withdrawn carefully which allowed retraction of several centimeters of the device.When the 4f sheath was completely withdrawn, the tip of the remaining shaft appeared just outside the remaining 6f sheath and the tip was trapped with a sterile clamp to successfully withdraw the entirety of the device.It was confirmed nothing was left in the patient.Due to manipulation with the sheaths, the patient had bleeding.A blood transfusion was performed.A crossover with another sheath was used with a covered stent to fully resolve the bleeding.The account states there was a clinically significant delay.No additional information was provided.
 
Manufacturer Narrative
(b)(4).The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.
 
Manufacturer Narrative
The device was returned for analysis.The reported material separation was confirmed.The reported difficulty removing the device could not be replicated in a testing environment due to the condition of the returned device.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.It was reported that the device was used to treat the tibial artery.It should be noted that the xience xpedition instructions for use (ifu) states: the xience xpedition everolimus eluting coronary stent system are indicated for improving coronary luminal diameter.The investigation was unable to determine a conclusive cause for the reported difficulty removing the device; however, the reported separation, removal of foreign body, delayed treatment and additional treatment appear to be related to operational context.There is no indication of a product quality issue with respects to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key12939095
MDR Text Key284685722
Report Number2024168-2021-11136
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeSZ
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/18/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/02/2022
Device Catalogue Number1070250-48
Device Lot Number9062741
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/10/2021
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/15/2021
Initial Date FDA Received12/06/2021
Supplement Dates Manufacturer Received01/06/2022
Supplement Dates FDA Received01/18/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/03/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
4F SHEATH; 6F SHEATH
Patient Outcome(s) Other; Required Intervention;
-
-